Number of Clinical Trials 2017
Explore the number of clinical trials conducted in various countries; critical for medical research and innovation.
Newer data is available: Number of Clinical Trials by country 2024 →
Where does your country rank? Pick it to see its position.
Related Health statistics
More ↓Interactive Map
Complete Data Rankings
- #1
United States
- #2
France
- #3
United Kingdom
- #4
Canada
- #5
Germany
- #6
China
- #7
South Korea
- #8
Spain
- #9
Italy
- #10
Denmark
Analysis: These countries represent the highest values in this dataset, showcasing significant scale and impact on global statistics.
- #133
Suriname
- #132
Rwanda
- #131
Paraguay
- #130
Papua New Guinea
- #129
State of Palestine
- #128
North Macedonia
- #127
Niger
- #126
Namibia
- #125
Morocco
- #124
Republic of Moldova
Context: These countries or territories have the lowest values, often due to geographic size, administrative status, or specific characteristics.
Insights by country
Martinique
In 2017, Martinique ranked #119 globally for the Number of Clinical Trials with a total of 1 trial. This figure is significantly lower than many of its Caribbean neighbors, which often have more robust healthcare research infrastructures. The limited number of clinical trials in Martinique can be attributed to its small population and geographic isolation, which pose challenges for recruitment and funding in clinical research initiatives.
Angola
In 2017, Angola had a global rank of #102 with a total of 1 clinical trial. This figure is notably low compared to more developed nations, reflecting the challenges in healthcare infrastructure and research funding in the country. Angola's limited number of clinical trials can be attributed to its ongoing economic recovery and the need for improved regulatory frameworks to attract research investments.
Belarus
In 2017, Belarus ranked #95 globally with a total of 2 clinical trials. This figure is notably low compared to neighboring countries like Poland, which has a significantly higher number of trials. The limited number of clinical trials in Belarus can be attributed to its smaller population size and a less developed pharmaceutical research sector, which impacts the overall capacity for clinical research activities.
Algeria
In 2017, Algeria ranked #86 globally with a total of 3 clinical trials. This figure is notably low compared to countries with more developed research infrastructures, such as the United States, which leads in clinical trials. The limited number of clinical trials in Algeria can be attributed to factors such as insufficient investment in healthcare research, a lack of regulatory framework, and challenges in attracting international pharmaceutical companies.
Czech Republic
The Czech Republic ranked #36 globally with a total of 40 clinical trials in 2017. This figure is notable compared to other Central European nations, reflecting a robust research environment. Factors contributing to this statistic include a strong healthcare infrastructure, a well-educated workforce, and favorable regulatory conditions for clinical research. Additionally, the country's strategic location in Europe enhances its attractiveness for international pharmaceutical companies.
Bulgaria
Bulgaria ranked #58 globally with a total of 14 clinical trials in 2017. This figure is relatively modest compared to leading nations in clinical research, reflecting the country's developing healthcare infrastructure. Factors contributing to Bulgaria's clinical trial activity include its strategic location in Europe, which facilitates access to diverse patient populations, and ongoing efforts to enhance regulatory frameworks for research. Additionally, the country's participation in EU health initiatives has aimed to improve clinical research capabilities.
Bangladesh
In 2017, Bangladesh ranked #42 globally with a total of 25 clinical trials. This figure is relatively low compared to leading countries in clinical research, which often conduct hundreds or thousands of trials annually. The growth of clinical trials in Bangladesh is influenced by its expanding healthcare sector and increasing investments in medical research, driven by both government initiatives and international partnerships.
Armenia
In 2017, Armenia ranked #93 globally with a total of 2 clinical trials. This number is notably lower than the global average, reflecting a limited capacity for clinical research compared to top-ranked countries. Factors such as Armenia's smaller population and less developed pharmaceutical sector contribute to this low figure, which impacts the country's ability to attract international research collaborations.
Belgium
In 2017, Belgium ranked #14 globally with a total of 248 clinical trials. This performance is notable compared to neighboring countries like France, which had a significantly higher number of trials. Belgium's strong pharmaceutical sector and favorable regulatory environment foster a robust landscape for clinical research, attracting both domestic and international investments.
Congo
Congo ranked #106 globally with 1 clinical trial in 2017. This figure is notably low compared to countries with more robust healthcare infrastructures, such as South Africa, which leads the region in clinical research activity.
The limited number of clinical trials in Congo can be attributed to economic challenges, insufficient funding for research initiatives, and a lack of established healthcare facilities capable of conducting such studies. Additionally, political instability may hinder foreign investment and collaboration in the clinical research sector.
Analysis & Context
In 2017, the United States led the world with the highest Number of Clinical Trials, totaling 5851. This year saw clinical trials ranging globally from a minimum of 1 to this maximum, across 133 countries. The global average was approximately 111.80 trials, while the median was significantly lower at 10, indicating a skewed distribution heavily influenced by top-performing countries.
Concentration of Clinical Trials in Developed Nations
The data reveals a clear concentration of clinical trials in developed countries, with France (1053), the United Kingdom (650), and Canada (642) following the United States. This pattern can be attributed to several key factors: robust healthcare infrastructure, significant investment in medical research, and favorable regulatory environments that encourage clinical development. For instance, the United States, with its extensive network of research institutions and pharmaceutical companies, naturally dominates this field. Similarly, Western European countries like France and the United Kingdom benefit from strong public and private sector collaboration in healthcare research.
Emerging Trends in Clinical Trials
Interestingly, China (543) and South Korea (452) are among the top ten countries for clinical trials, signaling a shift towards greater research activity in Asia. This is partly due to their growing pharmaceutical industries and increased government support for research and development. As these countries continue to expand their capabilities, they are likely to play an increasingly significant role in global clinical research. Additionally, Denmark (294) and Italy (312) maintain strong positions due to their established healthcare systems and emphasis on medical innovation.
Limited Activity in Developing Regions
The bottom end of the spectrum, with countries like Namibia, Cambodia, and Morocco conducting only one trial each, highlights disparities in clinical research activity. These countries often face challenges such as limited funding, infrastructural deficits, and a lack of skilled personnel, which hinder their ability to conduct extensive clinical trials. This gap underscores the need for international collaboration and investment to boost research capabilities in these regions, potentially opening doors for future medical advancements.
Analyzing Year-over-Year Changes
Examining the year-over-year changes, several countries experienced significant increases in their number of clinical trials. Turkey saw the most notable growth, with an increase of 127 trials, representing a 79.4% rise. This can be attributed to recent policy reforms aimed at attracting more clinical research. France and China also saw substantial increases, reflecting their ongoing investment in the health sector. Conversely, countries like Thailand and Chile experienced declines of 24 and 20 trials, respectively, due to factors such as regulatory challenges and economic constraints.
Overall, the 2017 data on the Number of Clinical Trials provides a snapshot of the global landscape in medical research, with developed nations leading the way, emerging markets showing promising growth, and developing regions facing ongoing challenges. Understanding these dynamics is crucial for stakeholders aiming to enhance global health outcomes through more equitable distribution of clinical research activities.
Frequently Asked Questions About Number of Clinical Trials in 2017
Which country conducted the most clinical trials in 2017?
The United States conducted the most clinical trials in 2017, with a total of 5,851 trials.
Which country conducted the fewest clinical trials in 2017?
Namibia conducted the fewest clinical trials in 2017, with only 1 trial.
What was the average number of clinical trials conducted per country in 2017?
The average number of clinical trials conducted per country in 2017 was 112.
What was the median number of clinical trials conducted per country in 2017?
The median number of clinical trials conducted per country in 2017 was 10.
Which countries were in the top 3 for the number of clinical trials conducted in 2017?
The top 3 countries for the number of clinical trials conducted in 2017 were the United States with 5,851 trials, France with 1,053 trials, and the United Kingdom with 650 trials.
How many countries conducted only 1 clinical trial in 2017?
Ten countries conducted only 1 clinical trial in 2017, including Namibia, Cambodia, and Morocco.
Data Source
Number of clinical trials | ClinicalTrials.gov via Our World in Data
Data produced by ClinicalTrials.gov, compiled and published by Our World in Data as "Number of clinical trials".
Visit Data SourceCite this page
Geo Factbook. (n.d.). Number of Clinical Trials by Country, 2017. Retrieved November 16, 2026, from https://geofactbook.com/fact/number-of-clinical-trials/2017
The figures on this page come from Number of clinical trials | ClinicalTrials.gov via Our World in Data. For academic work, cite the original source as well.
›Embed this ranking on your site
Free to embed with attribution. Shows the top 10 countries and links back to the full ranking.